Additionally, the accumulation of IBA1+ CD163low MDMs tightly correlates with the loss of hepatocytes and increased ductular reaction during the progression of MASLD, primary sclerosing cholangitis, primary biliary cholangitis, and alcoholic hepatitis [195,196]. This evidence concerns the gene AIF1 and metabolic dysfunction-associated steatotic liver disease.